Pharma & Biotech
LexaGene has a disruptive technology that meets critical needs of underserved markets
THC Global Group moves to product validation ahead of medicinal cannabis supply
Ozop Surgical hoping to disrupt spinal implant market with its BLIF technology
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.